{
    "clinical_study": {
        "@rank": "126219", 
        "acronym": "Nebuadom", 
        "arm_group": [
            {
                "arm_group_label": "Atrovent + Bricanyl or Atrovent + Ventolin", 
                "arm_group_type": "Experimental", 
                "description": "3 daily inhalations of Atrovent mixture to form Bricanyl or Ventolin form Atrovent 0,5mg/1ml Bricanyl 5mg/2ml Ventolin 5mg/2,5ml"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "1 capsule per day lactose (in addition to the standard optimized treatment)"
            }
        ], 
        "brief_summary": {
            "textblock": "Design studies of nebulization in COPD does not respond adequately to the clinically\n      relevant question: the intervention of administering nebulized bronchodilators at home it is\n      likely to make a profit, compared to the standard optimized treatment as defined by the\n      recommendations of the SPLF, patients with severe COPD (stage III, FEV between 30% and 50%\n      of the theoretical value) and very severe (stage IV, less than 30% of the theoretical value\n      FEV)? The concept of profit in this context is based on criteria of dyspnea, quality of\n      life, use of health system (exacerbations, hospitalizations, prescription of antibiotics and\n      steroids ...)."
        }, 
        "brief_title": "Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Severe Chronic Obstructive Pulmonary Disease", 
        "condition_browse": {
            "mesh_term": [
                "Lung Diseases", 
                "Respiration Disorders", 
                "Pulmonary Disease, Chronic Obstructive", 
                "Lung Diseases, Obstructive"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult\n\n          -  COPD Patients stage 3 et 4\n\n          -  Has not submitted an exacerbation in the 3 months preceding the pre-inclusion visit\n\n          -  Weaned from tobacco for at least 6 months\n\n          -  vaccinated against pneumococcal\n\n          -  Have not been included in a pulmonary rehabilitation program during the 6 months\n             preceding the screening visit inclusion\n\n          -  Patient pre-included not showing exacerbation since the pre-inclusion visit\n\n        Exclusion Criteria:\n\n          -  Patient under nebulizer or has been treated with nebulized bronchodilators at home\n             over the last 6 months\n\n          -  Patient with an indication of oxygen is expected in the coming year\n\n          -  Progressive malignant disease known\n\n          -  Patient under non-invasive ventilation (NIV) for less than 6 months or NIV provided\n             in the following year\n\n          -  Patient known to be colonized by Pseudomonas aeruginosa, A. xylosoxidans,\n             Burkholderia cepacia or Stenotrophomonas maltophilia\n\n          -  Patients with severe cardiovascular disease\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02103374", 
            "org_study_id": "PHRN10-PD/Nebuadom", 
            "secondary_id": [
                "2010-023743-14", 
                "2010-R38", 
                "A101466-30"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Atrovent + Bricanyl or Atrovent + Ventolin", 
                "description": "3 daily inhalations of Atrovent mixture to form Bricanyl or Ventolin form during 48 weeks", 
                "intervention_name": "Atrovent + Bricanyl or Atrovent + Ventoline", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "1 capsule lactose during 48 weeks", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug", 
                "other_name": "Placebo"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Albuterol", 
                "Terbutaline", 
                "Bronchodilator Agents", 
                "Ipratropium"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "weaned tobacco", 
            "Has not submitted an exacerbation in the past 3 months"
        ], 
        "lastchanged_date": "March 31, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Pierre-Alexandre ROGER"
                }, 
                "facility": {
                    "address": {
                        "city": "Amiens", 
                        "country": "France", 
                        "zip": "80054"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Pierre-Alexandre ROGER", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fr\u00e9d\u00e9ric GAGNADOUX, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Angers", 
                        "country": "France", 
                        "zip": "49033"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Fr\u00e9d\u00e9ric GAGNADOUX, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Aude BARNIER"
                }, 
                "facility": {
                    "address": {
                        "city": "Brest", 
                        "country": "France", 
                        "zip": "29609"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Aude BARNIER", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "S\u00e9bastien QUETANT"
                }, 
                "facility": {
                    "address": {
                        "city": "Grenoble", 
                        "country": "France", 
                        "zip": "38043"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "S\u00e9bastien QUETANT", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Boris MELLONI, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Limoges", 
                        "country": "France", 
                        "zip": "87042"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Boris MELLONI, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fran\u00e7ois CHABOT, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Nancy", 
                        "country": "France", 
                        "zip": "54511"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Fran\u00e7ois CHABOT, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Arnaud CAVAILLES"
                }, 
                "facility": {
                    "address": {
                        "city": "Nantes", 
                        "country": "France", 
                        "zip": "44093"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Arnaud CAVAILLES", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Bertrand LEMAIRE, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Orl\u00e9ans", 
                        "country": "France", 
                        "zip": "45067"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Bertrand LEMAIRE, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Nicolas ROCHE, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France", 
                        "zip": "75004"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Nicolas ROCHE, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fabrice CARON"
                }, 
                "facility": {
                    "address": {
                        "city": "Poitiers", 
                        "country": "France", 
                        "zip": "86000"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Fabrice CARON", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Fran\u00e7ois LEBARGY, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Reims", 
                        "country": "France", 
                        "zip": "51100"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Fran\u00e7ois LEBARGY, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jean-Fran\u00e7ois MUIR, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Rouen", 
                        "country": "France", 
                        "zip": "76031"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Jean-Fran\u00e7ois MUIR, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Patrice DIOT, MD-PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "Tours", 
                        "country": "France", 
                        "zip": "37044"
                    }, 
                    "name": "Service de Pneumologie"
                }, 
                "investigator": {
                    "last_name": "Patrice DIOT, MD-PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Evaluation of Benefit of Nebulized Bronchodilators at Home in Severe Chronic Obstructive Pulmonary Disease and Very Severe Steady State", 
        "other_outcome": [
            {
                "measure": "Number of exacerbations", 
                "safety_issue": "Yes", 
                "time_frame": "Patients will be followed for the duration of their participation ie 48 weeks"
            }, 
            {
                "measure": "Number of hospitalizations", 
                "safety_issue": "Yes", 
                "time_frame": "Patients will be followed for the duration of their participation ie 48 weeks"
            }
        ], 
        "overall_contact": {
            "email": "diot@med.univ-tours.fr", 
            "last_name": "Patrice DIOT, MD-PhD", 
            "phone": "+33 (0)2 47 47 80 32"
        }, 
        "overall_contact_backup": {
            "email": "marie.coudray@med.univ-tours.fr", 
            "last_name": "Marie COUDRAY", 
            "phone": "+33 (0)2 47 47 46 64"
        }, 
        "overall_official": {
            "affiliation": "University Hospital, Tours", 
            "last_name": "Patrice DIOT, MD-PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Score for quality of life, assessed by the questionnaire St Georges", 
            "safety_issue": "No", 
            "time_frame": "Patients will be followed for the duration of their participation ie 48 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02103374"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Score for quality of life, assessed by the questionnaire VQ11", 
                "safety_issue": "No", 
                "time_frame": "Patients will be followed for the duration of their participation ie 48 weeks"
            }, 
            {
                "measure": "Dyspnea score according Medical Research Council", 
                "safety_issue": "No", 
                "time_frame": "Patients will be followed for the duration of their participation ie 48 weeks"
            }, 
            {
                "measure": "Prognostic Score Mortality assessed by the score BODE", 
                "safety_issue": "No", 
                "time_frame": "Patients will be followed for the duration of their participation ie 48 weeks"
            }
        ], 
        "source": "University Hospital, Tours", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Tours", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}